The latest price target for Sempra (NYSE:SRE) was reported by Barclays on January 27, 2025. The analyst firm set a price target for $95.00 expecting SRE to rise to within 12 months (a possible 9.20% upside). 22 analyst firms have reported ratings in the last year.

The latest analyst rating for Sempra (NYSE:SRE) was provided by Barclays, and Sempra maintained their overweight rating.

The last upgrade for Sempra happened on December 13, 2024 when Morgan Stanley raised their price target to $98. Morgan Stanley previously had an equal-weight for Sempra.

The last downgrade for Sempra happened on March 7, 2022 when Keybanc changed their price target from N/A to N/A for Sempra.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sempra, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sempra was filed on January 27, 2025 so you should expect the next rating to be made available sometime around January 27, 2026.

While ratings are subjective and will change, the latest Sempra (SRE) rating was a maintained with a price target of $99.00 to $95.00. The current price Sempra (SRE) is trading at is $87.00, which is out of the analyst’s predicted range.